818 COVID-19 patients studied to uncover risk factors for severe disease
NCT ID NCT04887142
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed study enrolled 818 adults hospitalized with COVID-19 to examine how genetic, inflammatory, and other blood markers relate to disease severity and death. Researchers tracked outcomes like recovery or death and analyzed risk factors using statistical models. The goal was to better understand why some patients become severely ill, which could improve future care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this research could help doctors better predict which COVID-19 patients are at highest risk of severe illness or death, potentially guiding more personalized care.
What could go wrong
This is an observational study, not a treatment trial, so it cannot prove cause and effect. The findings may not apply to all populations or future virus variants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Faculty of Medical Sciences, University Clinical Center Kragujevac
Kragujevac, Srbija, 34000, Serbia
-
General Hospital "Prim. dr. Abdulah Nakaš"
Sarajevo, Bosnia and Herzegovina
-
KBC Rijeka, University of Rijeka
Rijeka, Croatia
-
Spitali Amerikan
Tirana, Albania
-
University of Montenegro, Faculty of Medicine
Podgorica, Montenegro